(10-028) Evaluating the Efficacy of Rifaximin Monotherapy versus Rifaximin Plus Lactulose for the Treatment of Recurrent Hepatic Encephalopathy in Hospitalized Patients with Cirrhosis
Wednesday, December 10, 2025
11:00 AM - 12:00 PM
Location: Bayside A, Level 1
Residency Program: Wellstar Cobb Medical Center / Wellstar Health System PGY1/PGY2 HSPAL Residency Program Type: PGY1 & PGY2 Combined (PGY1 Pharmacy & PGY2 Health System Pharmacy Administration and Leadership) Residency Program Location: Georgia
